Structural determinants of the blocker binding site in glutamate and NMDA receptor channels

Neuropharmacology

Volumn 37, Issue 2, 1998, Pages 139-147

  Ferrer Montiel, Antonio V ^a   Merino, Jaime M ^a   Planells Cases, Rosa ^a   Sun, William ^a   Montal, Mauricio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adamantane derivatives; Arylcyclohexylamines; Dibenzocycloheptenimines; Morphinian derivatives; Neuroprotectants

Indexed keywords

ADAMANTANE DERIVATIVE; ASPARAGINE; CYCLOHEXYLAMINE DERIVATIVE; DIVALENT CATION; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; THREONINE; TRYPTOPHAN;

ANIMAL CELL; ARTICLE; BINDING SITE; ELECTRIC FIELD; MEMBRANE CHANNEL; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; XENOPUS;

AMINO ACID SUBSTITUTION; ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; MUTAGENESIS, SITE-DIRECTED; PATCH-CLAMP TECHNIQUES; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; XENOPUS;

EID: 0032004097     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00007-0     Document Type: Article

References (61)

1. Ascher P., Nowak L. The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurons in culture. J. Physiol. 399:1988;247-266.
2. Bennett J.A., Dingledine R. Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop. Neuron. 14:1995;373-384.
3. Blanpied T.A., Boeckman F.A., Aizenman E., Johnson J.W. Trapping channel block of NMDA-activated responses by amantadine and memantine. J. Neurophysiol. 77:1997;309-323.
4. Bresink I., Benke T.A., Collett V.J. et al. Effects of memantine on recombinant rat NMDA receptors expressed in HEK293 cells. Br. J. Pharmacol. 119:1996;195-204.
5. Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron. 8:1992;189-198.
6. Burnashev N., Schoepfer R., Monyer H. et al. Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science. 257:1992;1415-1419.
7. Burnashev, N., Villarroel, A., Sakmann, B., 1996. Dimensions and ion selectivity of recombinant AMPA and kainate receptor channels and their dependence on Q/R site residues. J. Physiol. 496.1, 165-173.
8. Chen H.-S.V., Pellegrine J.W., Aggarwal S.K. et al. Open channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantages against NMDA receptor-mediated neurotoxicity. J. Neurosci. 12:1992;4427-4436.
9. Choi D.W., Rothmann S.M. The role of glutamate neurotoxicity in hypoxic ischemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
10. Choi D.W. Bench to bedside the glutamate connection. Science. 258:1992;241-243.
11. Collingridge G.L., Lester R.A.J. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 40:1989;143-210.
12. Dingledine R., Hume R.I., Heinemann S.F. Structural determinants of barium permeation and rectification in non-NMDA receptor channels. J. Neurosci. 12:1992;4080-4087.
13. Ferrer-Montiel A.V., Montal M. Structure-function relations in ligand-gated ion channels: Reconstitution in lipid bilayers and heterologous expression in Xenopus oocytes. Methods: A Companion to Methods in Enzymology. 6:1994;60-69.
14. Ferrer-Montiel A.V., Sun W., Montal M. Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine. Proc. Natl. Acad. Sci. USA. 92:1995;8021-8025.
15. Ferrer-Montiel A.V., Montal M. Pentameric subunit stoichiometry of a neuronal glutamate receptor. Proc. Natl. Acad. Sci. USA. 93:1996;2741-2744.
16. Ferrer-Montiel A.V., Sun W., Montal M. A single tryptophan on M2 of glutamate receptor channels confers high permeability to divalent cations. Biophys J. 71:1996;749-758.
17. Herrling, P.L., 1994. Clinical implications of NMDA receptors. In: Collingridge, G.L. (Ed.), The NMDA Receptor. IRL Press at Oxford, University Press, Oxford, pp. 376-394.
18. Hollmann M., Heinemann S.F. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
19. Hollmann M., Maron C., Heinemann S.F. N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1. Neuron. 13:1994;1331-1343.
20. Huettner J.E., Bean B.P. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc. Natl. Acad. Sci. USA. 85:1988;1307-1311.
21. Hume R.I., Dingledine R., Heinemann S.F. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science. 253:1991;1028-1031.
22. Iino M., Ozawa S., Tsuzuki K. Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurons. J. Physiol. 424:1990;151-165.
23. Iversen, L.L., Kemp, J.A., 1994. Non-competitive NMDA antagonists as drugs. In: Collingridge, G.L. (Ed.), The NMDA Receptor. IRL Press at Oxford, University Press, Oxford, pp. 468-486.
24. Jahr C.E., Stevens C.F. Calcium permeability of the N-methyl-D-aspartate receptor channel in hippocampal neurons in culture. Proc. Natl. Acad. Sci. USA. 90:1993;11573-11577.
25. Jessell, T.M., Kandel, E.R., 1993. Synaptic transmission: a bidirectional and self-modifiable form of cell-cell communication. Cell 72/Neuron 10 (Suppl), 1-30.
26. Jonas P., Burnashev N. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron. 15:1995;987-990.
27. Kawajiri S., Dingledine R. Multiple structural determinants of voltage-dependent magnesium block in recombinant NMDA receptors. Neuropharmacol. 32:1993;1203-1211.
28. Koroshetz W.J., Moskowitz M.A. Emerging treatments for stroke in humans. Trends Pharmacol. Sci. 17:1996;227-233.
29. Kuner T., Wollmuth L.P., Karlin A., Seeburg P.H., Sakmann B. Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines. Neuron. 17:1996;343-352.
30. 2+-block in NMDA receptor channels. J. Neurosci. 16:1996;3549-3558.
31. Kupper J., Ascher P., Neyton J. Probing the pore region of recombinant N-methyl-D-aspartate using external and internal magnesium block. Proc. Natl. Acad. Sci. USA. 93:1996;8648-8653.
32. Le Bourdelles B., Wafford K.A., Kemp J.A. et al. Cloning functional expression and pharmacological characterisation of human cDNAs encoding NMDA receptor NR1 and NR2A subunits. J. Neurochem. 62:1994;2091-2098.
33. Levitzki, A., 1984. Receptors: A Quantitative Approach. Benjamin Cummings, Menlo Park, CA, pp. 1-142.
34. 2+ of NMDA responses in spinal cord neurons. Nature. 309:1984;261-263.
35. Mayer M.L., Westbrook G.L. Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurons. J. Physiol. 394:1987;501-527.
36. McBurney R.W. Development of the NMDA ion-channel blocker, aptiganel hydrochloride as a neuroprotective agent for acute CNS injury. Int. Rev. Neurobiol. 40:1997;173-195.
37. 2+-permeability of AMPA-selective glutamate receptor channels. Biochem. Biophys. Res. Commun. 180:1991;813-821.
38. Montal M. Design of molecular function: Channels of communication. Annu. Rev. Biophys. Biomol. Struct. 24:1995;31-57.
39. 2+-block site of the NMDA receptor channel. Nature. 358:1992;673-675.
40. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
41. Nakanishi S., Masu M. Molecular diversity and functions of glutamate receptors. Annu. Rev. Biophys. Biomol. Struct. 23:1994;319-348.
42. Olney J.W. Excitotoxic amino acid and neuropsychiatric disorders. Annu. Rev. Pharmacol. Toxicol. 30:1990;47-71.
43. Parsons C.G., Gruner R., Rozental J., Millar J., Lodge D. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3-5-dimethyladamantan). Neuropharmacology. 32:1993;1337-1350.
44. Parsons C.G., Quack G., Bresink I. et al. Comparison of the potency kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology. 34:1995;1239-1258.
45. Planells-Cases R., Sun W., Ferrer-Montiel A.V., Montal M. Molecular cloning, functional expression and pharmacological characterization of an N-methyl-d-aspartate receptor subunit from human brain. Proc. Natl. Acad. Sci. USA. 90:1993;5057-5061.
46. Premkumar, L.S., Auerbach, A., 1996. Stoichiometry of recombinant NMDA receptor channels. Abstract Soc. Neurosci. 22, 593, Abs# 237.8.
47. Premkumar L.S., Auerbach A. Identification of a high affinity divalent cation binding site near the entrance of the NMDA receptor channel. Neuron. 16:1996;869-880.
48. 2+ and channel blockers by a single amino acid substitution in the N-methyl-D-aspartate receptor. J. Biol. Chem. 268:1993;410-415.
49. Schinder A.F., Olson E.C., Spitzer N.C., Montal M. Mitochondrial dysfunction is a primary event in glutamate excitotoxicity. J. Neurosci. 16:1996;6125-6133.
50. Sharma G., Stevens C.F. A mutation that alters magnesium block of N-methyl-D-aspartate receptor channels. Proc. Natl. Acad. Sci. USA. 93:1996;14170-14175.
51. Stevens, C.F., 1993. Quantal release of neurotransmitter and long-term potentiation. Cell 72/Neuron 10 (Suppl), 55-63.
52. Sun W., Ferrer-Montiel A.V., Schinder A.F., McPherson J.P., Evans G.A., Montal M. Molecular cloning, chromosomal mapping and functional expression of human brain glutamate receptors. Proc. Natl. Acad. Sci. USA. 89:1992;1443-1447.
53. Sutcliffe M.J., Wo G.Z., Oswald R.E. Three-dimensional models of non-NMDA glutamate receptors. Biophys. J. 70:1996;1575-1589.
54. Taverna F.A., Wang L., McDonald J.F., Hampson D.R. A transmembrane model for an ionotropic glutamate receptor predicted on the basis of the location of asparagine-linked oligosaccharides. J. Biol. Chem. 269:1994;14159-14164.
55. Verdoorn T.A., Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science. 252:1991;1715-1718.
56. Wo Z.G., Oswald R.E. Unraveling the modular design of glutamate-gated ion channels. Trends in Neurosci. 18:1995;161-168.
57. Wo Z.G., Bian Z.C., Oswald R.E. ASN-265 of frog kainate binding protein is a functional glycosylation site. Implications for the transmembrane topology of glutamate receptors. FEBS Lett. 368:1995;230-234.
58. Wollmuth L.P., Kuner T., Seeburg P.H., Sakmann B. Differential contribution of the NR1 NR2A-subunits to the selectivity filter of recombinant NMDA receptor channels. J. Physiol. 491:1996;779-797.
59. Woodhull A.M. Ionic blockage of sodium channels in nerve. J. Gen. Physiol. 61:1973;687-708.
60. Zarei M.M., Dani J.A. Ionic permeability characteristics of the N-methyl-D-aspartate receptor channel. J. Gen. Physiol. 103:1994;231-248.
61. Zarei M.M., Dani J.A. Structural basis for explaining open-channel blockade of the NMDA receptor. J. Neurosci. 15:1995;1446-1454.